Assignee
HYUNDAI PHARM CO LTD
KR·8 granted patents·2 pending applications·11 citations·filing 2014–2022
Top patents by PatentIndex Score
10 records- 0180US10821110B2Composite preparation, containing novel 3-(4--(benzyloxy)phenyl)hex-4-inoic acid derivative and another active ingredient, for preventing or treating metabolic diseasesHYUNDAI PHARM CO LTD·Filed 2015·Granted Nov 3, 2020·2 cites·22 claims
- 0277US9758527B2Cyclohexene derivative, preparation method therefor, and pharmaceutical composition for preventing or treating metabolic diseases, containing same as active ingredientHYUNDAI PHARM CO LTD·Filed 2015·Granted Sep 12, 2017·4 cites·8 claims
- 0373US9969723B23-(4-(benzyloxy)phenyl)hex-4-ynoic acid derivative, method of preparing same and pharmaceutical composition for preventing and treating metabolic disease including same as effective ingredientHYUNDAI PHARM CO LTD·Filed 2015·Granted May 15, 2018·2 cites·14 claims
- 0472US10292955B2Composition for external use preparation with improved transdermal permeabilityHYUNDAI PHARM CO LTD·Filed 2014·Granted May 21, 2019·3 cites·10 claims
- 0559US12540142B2Method for evaluating quality of (3S)-3-(4-(3-(1,4-dioxaspiro[4,5]dec-7-en-8-yl)benzyloxy)phenyl)hex-4-inoic acidHYUNDAI PHARM CO LTD·Filed 2021·Granted Feb 3, 2026·0 cites·8 claims
- 0653US2024197674A1Novel use of 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivativeHYUNDAI PHARM CO LTD·Filed 2022·Application pending·0 cites
- 0747US12516036B2Crystal form of 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivativeHYUNDAI PHARM CO LTD·Filed 2020·Granted Jan 6, 2026·0 cites·11 claims
- 0845US12421205B2GLP-1 receptor agonistHYUNDAI PHARM CO LTD·Filed 2020·Granted Sep 23, 2025·0 cites·15 claims
- 0935US2016355483A1Compound binding to pparg but not acting as promoter and pharmaceutical composition for treating pparg-related diseases containing same as active ingredientHYUNDAI PHARM CO LTD·Filed 2016·Application pending·0 cites
- 1034US10723699B2Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredientHYUNDAI PHARM CO LTD·Filed 2016·Granted Jul 28, 2020·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when HYUNDAI PHARM CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →